The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...
Stories by SWNS on MSN
Woman used Grey’s Anatomy to understand cancer diagnosis
A young woman had to rely on TV medical drama Grey’s Anatomy to understand her cancer diagnosis after poor communication from ...
A fundraiser this weekend aims to help a local teenager pursue her cheerleading dreams while fighting cancer. Ariana ...
Torryn Pinkard doesn’t want to be looked upon as someone with cancer who happens to play football. He’d rather be seen as a ...
FDA orphan drug designation provides incentives including regulatory support, tax credits, fee exemptions, and seven years of ...
Storm Therapeutics has closed a $56 million series C financing as the British biotech kicks off a phase 2 sarcoma trial of ...
In March of 2024, Eva—a bright, joyful seventh grader, a dancer at BTC, and a cheerleader at Southeast middle school—was ...
STORM Therapeutics raises $56M Series C and doses first patient in Phase 2 sarcoma trial of STC-15, the world’s first RNA ...
There are multiple fundraisers for the family of Vinny Trotter, who died in a construction accident. His oldest son was ...
The proceeds will support the advancement of STC-15 in a Phase 2 study in select sarcoma indicationsFirst‑in‑class METTL3 inhibitor reprograms ...
RNA epigenetics specialist Storm Therapeutics Ltd. has closed a $56 million series C to fund phase II development of its lead RNA enzyme inhibitor, STC-15, in treating myo- and liposarcomas, and ...
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a clinical-stage biotechnology company targeting cancer and autoimmune diseases, today announces that the United States Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results